Related Experiment Video
Updated: Mar 15, 2026

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
Triterpenoids from Ganoderma angustisporum and their α-glucosidase inhibitory activities
Fan-Ru Xu1,2, Le Zhou3, Yu-Cheng Dai4
1CAS Key Laboratory of Forest Ecology and Silviculture, Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, P. R. China.
Abstract:
A novel triterpenoid, (22S, 24E)-3β, 15, 22-triacetoxy-6-oxolanosta-9, 24-dien-26-oic acid (1), together with eight previously identified analogues, was isolated from the solid-substrate culture of Ganoderma angustisporum J.H. Xing, B.K. Cui & Y.C. Dai. Their chemical structures were elucidated based on a comprehensive set of spectroscopic techniques, including 1D and 2D NMR as well as HRESIMS data. All obtained compounds were screened for α-glucosidase inhibitory activity. Compound 2 demonstrated potent inhibition (IC50 = 18.26 ± 2.36 μM), exhibiting comparable activity to the positive control acarbose (IC50 = 15.24 ± 2.63 μM). Molecular docking showed that compound 2 binds to the hydrophobic pocket of α-glucosidase by forming hydrogen bonds with Arg359, stabilising the complex with a binding energy of -7.2 kcal/mol.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Enzyme Inhibition
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...

